KMB +0.21% NVDA -0.82% ^GSPC +2.35% Explore stocks on Coinbase Trading disclosure Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
It's fair to wonder what's going on with Kimberly-Clark (NASDAQ: KMB). Its shares have dropped 16.5% over the last five years through Nov. 5. That's badly lagged the S&P 500 index's 56.5% gain.
Clearly, the company has had issues. What are they, and has Kimberly-Clark moved past them?
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Kimberly-Clark, maker of items like tissues and diapers, has seen sales drop for the last couple of years. Looking beyond the headline figures tells a better, though not great, story.
In 2025, the company's top line fell 2.9%, due to the sale of businesses that no longer generated sales and unfavorable foreign-currency translation.
On a comparable basis, excluding sold businesses and foreign-currency translations, Kimberly-Clark's sales grew 1.7%. That was due to higher volume, which contributed 2.5 percentage points. Still, that's tepid sales growth. And competitive pressures forced the company to lower prices on certain items.
Sales trends worsened this year, however. Kimberly-Clark's third-quarter adjusted sales dropped 1.3% compared to a year ago. The company's adjusted gross margin got squeezed, contracting 1.3 percentage points.
Amid sluggish sales, Kimberly-Clark recently completed the large acquisition of Kenvue. While the deal will expand the company's product portfolio with brands including Tylenol, Listerine, and Band-Aid, the transaction has large risks. These include the time, money, and risk of integrating a large business.
With Kimberly-Clark already facing pressure on its own sales, management took on major challenges by buying Kenvue. That's why, despite Kimberly-Clark having a stable of known brands, I'd pass on the shares right now.
Before you buy stock in Kimberly-Clark, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Kimberly-Clark wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $341,966!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,146,819!*
Now, it's worth noting Stock Advisor's total average return is 852% — a market-crushing outperformance compared to 203% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of November 10, 2026.
Lawrence Rothman, CFA has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
What's Wrong With Kimberly-Clark Stock? was originally published by The Motley Fool
